The JAK2 V617F mutation in lung cancer: caveat emptor
Langabeer, S.E.
Experimental Oncology 40(4): 343-344
2018
ISSN/ISBN: 1812-9269 PMID: 30593755 Document Number: 697654
Document emailed within 1 workday
Related Documents
Gochman, N.; Schmitz, J.M. 1972: "Caveat emptor"--uricase Clinical Chemistry 18(5): 492Leigh, G.; Loewen, I.; Lester, M. 1986: Caveat emptor: Values and ethics in family life education and enrichment Family relations 35(4): 573-580
Mykitiuk, R. 2004: Caveat emptor: direct-to-consumer supply and advertising of genetic testing Clinical and Investigative Medicine. Medecine Clinique et Experimentale 27(1): 23-32
Da, J.; Chen, L.; Hu, Y. 1996: Human papillomavirus infection and p53 gene mutation in primary lung cancer Zhonghua Zhong Liu Za Zhi 18(1): 27-29
Zhang, J.Q.; Xu, F.; Xu, X.L.; Zhou, H.C. 2017: Erlotinib in the treatment of small cell lung cancer with EGFR mutation: a case report Zhonghua Zhong Liu Za Zhi 39(9): 717-719
Hirai, Y.; Shimizu, Y.; Oura, S.; Yoshimasu, T.; Ota, F.; Nakamura, R.; Naito, K.; Nishiguchi, H.; Hashimoto, S.; Okamura, Y. 2012: The importance of p53 and ras mutation as predictive markers for adjuvant chemotherapy in non-small-cell lung cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(3): 381-384
Fu, D.; Liu, B.; Wang, H. 1997: Detection of p53 gene mutation in paraffin-embedded asbestos-related lung cancer tissue Zhonghua Yu Fang Yi Xue Za Zhi 31(4): 206-208
Karnaoukhova, L.; Moffat, J.; Martins, H.; Glickman, B. 1997: Mutation frequency and spectrum in lymphocytes of small cell lung cancer patients receiving etoposide chemotherapy Cancer Research 57(19): 4393-4407
Dou, Y.-l.; Qi, X.-l.; Xin, L.; Chen, D.; Zhang, H.-q.; Cui, Q.-c. 2013: Value of detecting epidermal growth factor receptor mutations in non-small cell lung cancer tissue by TaqMan-amplification refractory mutation system Zhonghua Yi Xue Za Zhi 93(10): 768-771
Li, Z.; Zhang, L-jun.; Wang, W-ping.; Guo, K.; Shao, J-yong.; Rong, T-hua. 2011: Correlation between EGFR gene mutation and high copy number and their association with the clinicopathological features in Chinese patients with non-small cell lung cancer Zhonghua Zhong Liu Za Zhi 33(9): 666-670
Motomura, Y.; Mori, T.; Furuhashi, S.; Hayashi, N.; Suzumura, T.; Yamanaka, T.; Sakamoto, O.; Kuriwaki, K.; Kanemitsu, K.; Suzuki, M. 2015: Collision Lung Cancer Consisting of Squamous Cell Carcinoma and Adenocarcinoma which Showed Identical Epidermal Growth Factor Receptor Mutation;Report of a Case Kyobu Geka. Japanese Journal of Thoracic Surgery 68(9): 793-796
Shi, Y. 2015: The Guideline for Diagnosis and Treatment of Chinese Patients with sensitizing EGFR Mutation or ALK Fusion Gene-Positive Non-Small Cell Lung Cancer (2015 Version) Zhonghua Zhong Liu Za Zhi 37(10): 796-799
Zhu, Z.; Li, L.; Zhu, Y. 1996: Detection of p53 gene mutation in bronchial biopsy samples from lung cancer patients with polymerase chain reaction-single strand conformation polymorphism-silver staining method Zhonghua Nei Ke Za Zhi 35(11): 738-740
Hillerdal, G. 1999: Recommendations by the Swedish lung cancer group. Shorter waiting time is a quality requirement in the management of lung cancer Lakartidningen 96(43): 4691
Levin, W.J.; Press, M.F.; Gaynor, R.B.; Sukhatme, V.P.; Boone, T.C.; Reissmann, P.T.; Figlin, R.A.; Holmes, E.C.; Souza, L.M.; Slamon, D.J. 1995: Expression patterns of immediate early transcription factors in human non-small cell lung cancer. the Lung Cancer Study Group Oncogene 11(7): 1261-1269
McCormack, V.A.; Hung, R.J.; Brenner, D.R.; Bickeböller, H.; Rosenberger, A.; Muscat, J.E.; Lazarus, P.; Tjønneland, A.; Friis, Søren.; Christiani, D.C.; Chun, E-Mi.; Le Marchand, L.; Rennert, G.; Rennert, H.S.; Andrew, A.S.; Orlow, I.; Park, B.; Boffetta, P.; Duell, E.J. 2011: Aspirin and NSAID use and lung cancer risk: a pooled analysis in the International Lung Cancer Consortium (ILCCO) Cancer Causes and Control: Ccc 22(12): 1709-1720
Evans, W.K. 1997: Cost-effectiveness of gemcitabine in stage IV non-small cell lung cancer: an estimate using the Population Health Model lung cancer module Seminars in Oncology 24(2 Suppl 7: S7
El-Akawi, Z.J.; Nusier, M.K.; Zoughool, F.E. 2006: Relationship between alpha-1 antitrypsin deficient genotypes S and Z and lung cancer in Jordanian lung cancer patients Saudi Medical Journal 27(2): 181-184
Miyamoto, T.; Inoue, M.; Tanemura, M.; Yamaguchi, M.; Irei, T.; Tamaru, K.; Seo, S.; Misumi, T.; Shimizu, W.; Suzuki, T.; Onoe, T.; Sudo, T.; Shimizu, Y.; Hinoi, T.; Tashiro, H. 2018: A Resectable Case of TS-1 Therapy Useful in Distinguishing Primary Lung Cancer from Lung Metastases of Pancreatic Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 45(1): 88-90
Perng, R.P.; Chien, K.Y.; Chen, K.Y. 1989: Combined modality treatment for non-small cell lung cancer. Lung Cancer Study Group Zhonghua Yi Xue Za Zhi 43(4): 217-222